FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention generally relates to a pharmaceutically acceptable salt of the compound of formula (IV), wherein the salt contains a halide, phosphate, sulphate, trifluoroacetate, toluenesulphonate, acetate, mesylate (methanesulphonic) or benzoate anion; R1 is phenyl which is optionally substituted with halogen or C1-6 alkyl; R3, R4, R5 and R6 can be identical or different and separately represent hydrogen or halogen; m is equal to 3; n equals 1. Pharmaceutically acceptable salt of the compound of formula (IV) is obtained by reacting a compound of formula (II), where each of R2, identical or different, is hydrogen or tert-butoxycarbonyl, provided that at least one of R2 is tert-butoxycarbonyl with an acid to form a pharmaceutically acceptable salt of the compound of formula (IV). Invention also relates to a method of producing a pharmaceutically acceptable salt of a compound of formula (V) comprising reacting a pharmaceutically acceptable salt of the compound of formula (IV) with a fluoride source in the presence of ammonium, carbonate or bicarbonate salt to form a pharmaceutically acceptable salt of the compound of formula (V). Invention relates to salt of formula (VI) and (VII), where X is formate or ascorbate, respectively.
EFFECT: compounds of formula (VI) and (VII) are intended for preparing a pharmaceutical composition for visualizing heart failure in a subject.
47 cl, 7 tbl, 10 dwg, 32 ex
Title | Year | Author | Number |
---|---|---|---|
METHODS AND APPARATUS FOR SYNTHESIZING IMAGING AGENTS, AND INTERMEDIATES THEREOF | 2011 |
|
RU2631500C2 |
CONTRAST AGENT FOR MYOCARDIAL PERFUSION VISUALIZATION | 2012 |
|
RU2629840C2 |
EFFICIENT SYNTHESIS OF ETHYLENEDICYSTEINE-SUGAR CONJUGATES FOR IMAGING AND THERAPY | 2013 |
|
RU2674673C2 |
THERAPEUTIC COMPOUNDS AND COMPOSITIONS | 2019 |
|
RU2813780C2 |
11,13-MODIFIED SAXITOXINS FOR PAIN TREATMENT | 2018 |
|
RU2778455C2 |
ORAL CARE COMPOSITIONS | 2013 |
|
RU2683030C1 |
PSMA-BINDING AGENTS AND USING THEM | 2009 |
|
RU2494096C2 |
DERIVATIVES OF TRICYCLIC INDOLE AS PBR LIGANDS | 2011 |
|
RU2551423C2 |
4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUNDS | 2009 |
|
RU2515612C2 |
IMIDAZO[4,5-C]PYRIDINE DERIVATIVES AS TOLL-LIKE RECEPTOR AGONISTS | 2020 |
|
RU2785124C1 |
Authors
Dates
2020-01-10—Published
2011-05-11—Filed